This CBD stock could potentially generate 716.8% Profit in no time...

This CBD stock could potentially generate 716.8% Profit in no time...

June 10, 2019 -- InvestorsHub NewsWire -- If you don't know, consumers just celebrated the largest cannabis holiday on April 20th. Now, this holiday may have increased earnings for various cannabis companies, as well as cannabidiol (CBD) companies. However, with CBD - it's different. You see, CBD is non-psychoactive and helps provide pain relief, as well as treat various symptoms.

Consequently, CBD is becoming widely accepted by consumers and countries. For example, in the U.S., CBD became legal after the Farm Bill that passed in late 2018.

That in mind, consumers could easily find CBD products across the U.S. In turn, we may actually see some CBD companies generating more revenues and earnings than cannabis companies.

Now, Bethany Gomez, a researcher for The Brightfield Group estimate that the CBD market will reach $22B by 2022.  What's even more positive is Europe is just starting to get into the game and our next pick is a first-mover in the European CBD Market.

That said, CBD companies could experience exponential growth rates with such a large market. Not only that, large-cap drug stores like CVS and Walgreens have bet on CBD.

Additionally, CVS and Walgreens noted they would offer CBD products in more than 2,000 stores across the U.S.

But these companies need to find a reputable source for CBD products. Now, this one little-known company focused on CBD has figured out how to create CBD Isolate for $744 per kg. Their first crop is due in August 2019 and expected to produce 16,000 kg of CBD Isolate.  The current U.S. wholesale price for CBD Isolate is $6,077 per kg.

That would be a 716.8% Profit Margin!

 

With CVS and Walgreens offering CBD products, it wouldn't be surprising to see either of these two large drug store companies to strike a partnership with this CBD company.

Here are four major reasons why this CBD company could break out BIG:

1. Massive 3,706 acre Hemp farm in Poland scheduled to have its first crop in August
2. With a production output estimated at 16,000 kg in 2019, forecasted revenue can be expected to be an impressive $97.23 million and $197 million in 2020.
3. Raised CAD $24.36 in April, 2019
4. An extraction contract with DragonFly Biosciences, Europe's largest CBD retailer, is worth $48 million over the next three years.

It seems like this company's future is unstoppable.  Who can compete with them to produce at these levels?  We haven't found one yet…

It's always fun to share a secret like this with investors like you, but the word may get out quickly and the stock may not sit at these levels for long.

Get the full meal deal here.